KEY CLIENT FIDUCIARY ADVISORS, LLC Adaptimmune Therapeutics plc Transaction History

KEY CLIENT FIDUCIARY ADVISORS, LLC portfolio value:

$469,000
portfolio value

KEY CLIENT FIDUCIARY ADVISORS, LLC quarter portfolio value change:

-36.76%
quarter

Adaptimmune Therapeutics plc 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +4.76% 19.81K shares -238K $1.08 435.98K
Q2 2022 share Decrease -1.02% -4.28K shares -159K $1.7 416.16K
Q1 2022 share Increase +64.21% 164.39K shares -94K $2.06 420.44K
Q1 2022 call Decrease -100.00% -10K shares -38K $2.06 0
Q4 2021 share Increase 0.00% 256.04K shares 960K $3.87 256.04K
Q4 2021 call Increase 0.00% 10K shares 38K $3.87 10K